Summary

Based on the criteria you provided, the list of diseases contains a large number of hereditary, neurological and metabolic conditions. However, to find those that are frequently being studied in clinical trials (that is, research investigating the causes, symptoms, mechanisms and treatments of these diseases), we must filter out those that are of active clinical interest rather than those that are defined only by their name.

Below, I present a selection of diseases that meet the criteria of being "hereditary" (such as "Deficit...", "Degeneration...", "Dementia...", "Fibrosis...", "Hyperlipidemia...", "Adrenal insufficiency..."), which are of great clinical relevance for the development of current clinical trials.

### Conditions of High Active Clinical Interest

1. Fabry disease
* Cause: Biotinidase deficiency (genetic defect).
* Reason for trials: It is a hereditary metabolic disease that directly affects vascular tissues (muscles, glands) and is the main reason for great research on anti-immune, anti-VEGF treatments and supportive therapies for the patient.

2. Gaucher Disease
* Cause: Glucocerebrosidase deficiency (genetics).
* Rationale for trials: There is a vast literature on treatment trials, including supportive therapies (such as administration of phosphatecercosides), antiviral drugs (AICs), and pharmacokinetic and pharmacodynamic trials.

3. Glanzmann's disease
* Cause: Deficiency of the enzyme glucocerebrosidase (genetic).
* Reason for trials: The study is of great interest to understand the pathophysiology of the intestine and the absorption of lipopolyglucan and its relationship with childhood growth, which ranges from nutrition trials to therapies for premature growth.

4. Hyperlipidemia type IIa
* Cause: Genetic test (Hyperinsulinism).
* Reason for trials: It is a common laboratory finding in pediatric patients that correlates with nervous system development. The trials are focused on the identification of genetic markers and studies of response to treatments in patients with this condition.

5. Combined immunodeficiency
* Cause: Multifaceted genetics (Deficiencies in several growth factors and antibodies).
* Reason for trials: It is a fundamental pillar of medical research in immunology and pediatrics. The trials seek therapies for immunodeficiency (anti-TNF, biologics for combined immunodeficiency, supportive therapies in neonatology).

6. Lymphocytic leukemia (acute and recurrent)
* Cause: Genetic test (Deficiency of clavicle, stem cells or differentiation promoters).
* Reason for trials: It is a very active hematological disease. Clinical trials include chemotherapy trials, supportive therapies, remission pharmacology trials, and cancer biology research trials.

7. Hereditary sensory-motor neuropathy
* Cause: Genetic test (Deficiencies in growth factors or specific antigens).
* Reason for essays: It belongs to the category of "Rare Diseases" that begin with 'N'. The trials investigate the biology of neuropathic pain, pain signaling pathways and patient management.

8. Neurofibromatosis
* Cause: Genetic test (Deficiencies in growth factors or specific antigens).
* Reason for trials: It is studied in university and university centers to investigate diseases associated with the central nervous system (Ehlers-Danlos, fibromuscular, etc.).

9. Osteosarcoma
* Cause: Genetic test (Deficiencies in growth factors or specific antigens).
* Reason for trials: In European countries, l

Title

European Clinical Trials Information Network | We connect patients with clinical trials

Description

Discover ClinicalTrials.eu – a patient-centric platform connecting you to clinical trials across Europe. Find trustworthy, localized trial information for your disease. Empowering patients, research centers, and sponsors. Explore now!

Keywords

sarcoma, neoplasia, carcinoma, para, glioma, adenocarcinoma, fibrosis, europa, mama, melanoma, tumor, urticaria

NS Lookup

A 104.26.11.42, A 172.67.68.127, A 104.26.10.42

Dates

Created 2026-03-14

Updated 2026-04-13

Summarized 2026-04-14